A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 771,2 kr, with a 24-hour trading volume of 3,21B kr. The asset's market cap is 2,74T kr, after moving 1.74% in the last day.
Tokenized AstraZeneca PLC is trading at 890,59 kr, with a tokenized market cap of 121,99M kr and a 24-hour trading volume of 7,37M kr. The tokenized asset has moved -0.31% in the past 24 hours.